A
Amy L. Peterson
Researcher at University of Wisconsin-Madison
Publications - 33
Citations - 552
Amy L. Peterson is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Medicine & Familial hypercholesterolemia. The author has an hindex of 6, co-authored 24 publications receiving 273 citations. Previous affiliations of Amy L. Peterson include University of Wisconsin Hospital and Clinics.
Papers
More filters
Journal ArticleDOI
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.
Sarah D. de Ferranti,Julia Steinberger,Rebecca K. Ameduri,Annette L. Baker,Holly C. Gooding,Aaron S. Kelly,Michele Mietus-Snyder,Mark Mitsnefes,Amy L. Peterson,Julie St-Pierre,Elaine M. Urbina,Justin P. Zachariah,Ali N. Zaidi +12 more
TL;DR: This scientific statement presents considerations for clinical management regarding the assessment and risk reduction of select pediatric populations at high risk for premature cardiovascular disease, including acquired arteriosclerosis or atherosclerosis.
Journal ArticleDOI
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action
Katherine Wilemon,Jasmine Patel,Carlos A. Aguilar-Salinas,Catherine D. Ahmed,Mutaz Alkhnifsawi,Wael Almahmeed,Rodrigo Alonso,Khalid Al-Rasadi,Lina Badimon,Luz M Bernal,Martin Prøven Bogsrud,Lynne T. Braun,Liam R. Brunham,Alberico L. Catapano,Kristyna Cillíková,Pablo Corral,Regina Cuevas,Joep C. Defesche,Olivier S. Descamps,Sarah D. de Ferranti,Sarah D. de Ferranti,Jean-Luc Eiselé,Gerardo Elikir,Emanuela Folco,Tomáš Freiberger,Francesco Fuggetta,I.M. Gaspar,Ákos G Gesztes,Urh Groselj,Ian Hamilton-Craig,Gabriele Hanauer-Mader,Mariko Harada-Shiba,Gloria Hastings,G. Kees Hovingh,Maria Cristina de Oliveira Izar,Allison Jamison,Gunnar N Karlsson,Meral Kayıkçıoğlu,Sue Koob,Masahiro Koseki,Stacey R. Lane,Marcos M. Lima-Martínez,Greizy López,Tania Leme da Rocha Martinez,David Marais,Letrillart Marion,Pedro Mata,Inese Maurina,Diana Maxwell,Roopa Mehta,George A. Mensah,André R. Miserez,Dermot Neely,Stephen J. Nicholls,Atsushi Nohara,Børge G. Nordestgaard,Børge G. Nordestgaard,Leiv Ose,Leiv Ose,Athanasios Pallidis,Jing Pang,Jules Payne,Amy L. Peterson,Monica P Popescu,Raman Puri,Kausik K. Ray,Ashraf Reda,Tiziana Sampietro,Raul D. Santos,Inge Schalkers,Laura Schreier,Michael D. Shapiro,Eric J.G. Sijbrands,Daniel Soffer,Claudia Stefanutti,Mario Stoll,Rody G. Sy,Martha L. Tamayo,Myra Tilney,Myra Tilney,Lale Tokgozoglu,Brian Tomlinson,Antonio J. Vallejo-Vaz,Alejandra Vázquez-Cárdenas,Patrícia Vieira de Luca,David S. Wald,Gerald F. Watts,Gerald F. Watts,Nanette K. Wenger,Michaela Wolf,Darien Wood,Aram Zegerius,Thomas A. Gaziano,Thomas A. Gaziano,Samuel S. Gidding +94 more
TL;DR: The Global Call to Action on Familial Hypercholesterolemia thus represents individuals with FH, advocacy leaders, scientific experts, policy makers, and the original authors of the 1998 World Health Organization report.
Journal Article
A review of guidelines for dyslipidemia in children and adolescents.
TL;DR: The recent publication of new pediatric lipid screening guidelines represents a change in recommendations regarding lipid screening and management for pediatric patients that will affect all health care professionals who care for children and adolescents.
Journal ArticleDOI
Improving Universal Pediatric Lipid Screening.
TL;DR: Improved adherence to recommendations for universal lipid screening is possible through educational initiatives and EHR modifications, and inclusion of 12‐ to 16‐year‐old adolescents/teenagers as a targeted group for universal screening in addition to recommended age groups improved screening prevalence.
Journal ArticleDOI
In Pediatric Familial Hypercholesterolemia, Lipoprotein(a) Is More Predictive than LDL-C for Early Onset of Cardiovascular Disease in Family Members
TL;DR: Measurement of Lp(a) in children with FH may better characterize their cardiovascular risk, particularly when knowledge of family history is limited, and identify children withFH that could benefit from more aggressive management to reduce ASCVD risk.